UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Abstract IA018: Cancer immune-interception in Lynch Syndrome: Neoantigen-based vaccine development

Cancer prevention research (Philadelphia, Pa.), 2022-12, Vol.15 (12_Supplement_2), p.IA018-IA018

Vilar-Sanchez, Eduardo

2022

Volltextzugriff (PDF)

Genomic Analyses of Pre-cancers to Accelerate Cancer Interception in Hereditary Colorectal Cancer Syndromes

Annals of oncology, 2019-10, Vol.30, p.vi4

Vilar-Sanchez, Eduardo

2019

Volltextzugriff (PDF)

Abstract IA026: Novel insights into colorectal pre-cancers from hereditary cancer syndromes: From omics to interception

Cancer research (Chicago, Ill.), 2022-12, Vol.82 (23_Supplement_1), p.IA026-IA026

Vilar-Sanchez, Eduardo

2022

Volltextzugriff (PDF)

MP47-20 UNIVERSAL GERMLINE GENETIC TESTING OF PATIENTS WITH NEWLY DIAGNOSED UPPER TRACT UROTHELIAL CARCINOMA: AN INTERIM ANALYSIS

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Rarity of acquired mutations (MTs) after first-line therapy with anti-EGFR therapy (EGFRi)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3514-3514

2021

Volltextzugriff (PDF)

Clinical outcomes following termination of immunotherapy due to long-term benefit in MSI-H colorectal cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3585-3585

2022

Volltextzugriff (PDF)

Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.5074-5074

2019

Volltextzugriff (PDF)

Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.21-21

2020

Volltextzugriff (PDF)

Lorpucitinib (JNJ-64251330) in patients with familial adenomatous polyposis (FAP): Results from a phase 1b study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10514-10514

2023

Volltextzugriff (PDF)

Are current family-history based colorectal cancer screening guidelines adequate for early detection and potential prevention of young-onset cases?

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3549-3549

2021

Volltextzugriff (PDF)

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3520-3520

2022

Volltextzugriff (PDF)

Resistance mechanisms to anti-EGFR therapy in RAS/RAF wildtype colorectal cancer varies by regimen and line of therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3554-3554

2022

Volltextzugriff (PDF)

Exploring the genetic basis of Lynch-like syndrome through paired germline and tumor exome sequencing

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3592-3592

2019

Volltextzugriff (PDF)

Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells

Gastroenterology (New York, N.Y. 1943), 2018-07, Vol.155 (1), p.210-223.e3

2018

Volltextzugriff (PDF)

EJS-2Genomic Analyses of Pre-cancers to Accelerate Cancer Interception in Hereditary Colorectal Cancer Syndromes

Annals of oncology, 2019-10, Vol.30 (Supplement_6)

Vilar-Sanchez, Eduardo

2019

Volltextzugriff (PDF)

36 Analysis of T-cell receptor sequences identifies signatures associated with neoantigen exposure in peripheral blood of lynch syndrome patients

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A39-A39

2022

Volltextzugriff (PDF)

A phase II study of durvalumab (MEDI4736) (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.152-152

2020

Volltextzugriff (PDF)

Metachronous colorectal pathology among survivors of young-onset colorectal cancer: Implications for postresection colonoscopic surveillance

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.64-64

2020

Volltextzugriff (PDF)

PD15-04 GENOTYPE-PHENOTYPE CHARACTERIZATION OF LYNCH SYNDROME ASSOCIATED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival

Annals of surgical oncology, 2017-12, Vol.24 (13), p.4051-4058

2017

Volltextzugriff (PDF)

Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2520-2520

2021

Volltextzugriff (PDF)

Abstract CT236: A phase 1b, multicenter, randomized, blinded, placebo-controlled study to evaluate the efficacy of guselkumab in subjects with familial adenomatous polyposis

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT236-CT236

2020

Volltextzugriff (PDF)

Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3533-3533

2018

Volltextzugriff (PDF)

Early outcomes of a high-risk cohort in pancreatic cancer surveillance

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16258-e16258

2018

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Colorectal Cancer
(4)
Life Sciences & Biomedicine
(4)
Science & Technology
(4)
Gastroenterology & Hepatology
(3)
Humans
(3)
Cancer
(2)
Female
(2)
Gastroenterology
(2)
Gene Expression Regulation, Neoplastic
(2)
Genetic Disorders
(2)
Immunotherapy
(2)
Male
(2)
Middle Aged
(2)
Polyps
(2)
T Cell Receptors
(2)
Tumorigenesis
(2)
Adenocarcinoma In Situ - Genetics
(1)
Adenocarcinoma In Situ - Immunology
(1)
Akt Protein
(1)
Aldehyde Dehydrogenase - Genetics
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer

Abstract IA018: Cancer immune-interception in Lynch Syndrome: Neoantigen-based vaccine development

Genomic Analyses of Pre-cancers to Accelerate Cancer Interception in Hereditary Colorectal Cancer Syndromes

Abstract IA026: Novel insights into colorectal pre-cancers from hereditary cancer syndromes: From omics to interception

MP47-20 UNIVERSAL GERMLINE GENETIC TESTING OF PATIENTS WITH NEWLY DIAGNOSED UPPER TRACT UROTHELIAL CARCINOMA: AN INTERIM ANALYSIS

Rarity of acquired mutations (MTs) after first-line therapy with anti-EGFR therapy (EGFRi)

Clinical outcomes following termination of immunotherapy due to long-term benefit in MSI-H colorectal cancer

Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention

Lorpucitinib (JNJ-64251330) in patients with familial adenomatous polyposis (FAP): Results from a phase 1b study

Are current family-history based colorectal cancer screening guidelines adequate for early detection and potential prevention of young-onset cases?

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer

Resistance mechanisms to anti-EGFR therapy in RAS/RAF wildtype colorectal cancer varies by regimen and line of therapy

Exploring the genetic basis of Lynch-like syndrome through paired germline and tumor exome sequencing

Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells

EJS-2Genomic Analyses of Pre-cancers to Accelerate Cancer Interception in Hereditary Colorectal Cancer Syndromes

36 Analysis of T-cell receptor sequences identifies signatures associated with neoantigen exposure in peripheral blood of lynch syndrome patients

A phase II study of durvalumab (MEDI4736) (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

Metachronous colorectal pathology among survivors of young-onset colorectal cancer: Implications for postresection colonoscopic surveillance

PD15-04 GENOTYPE-PHENOTYPE CHARACTERIZATION OF LYNCH SYNDROME ASSOCIATED UPPER TRACT UROTHELIAL CARCINOMA (UTUC)

Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival

Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors

Abstract CT236: A phase 1b, multicenter, randomized, blinded, placebo-controlled study to evaluate the efficacy of guselkumab in subjects with familial adenomatous polyposis

Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC)

Early outcomes of a high-risk cohort in pancreatic cancer surveillance

Suchergebnisse filtern